Eton Pharmaceuticals (ETON) Accumulated Expenses (2017 - 2025)

Eton Pharmaceuticals (ETON) has 9 years of Accumulated Expenses data on file, last reported at $9.4 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses rose 5.54% year-over-year to $9.4 million; the trailing twelve-month figure through Dec 2025 stood at $9.4 million (up 5.54% YoY), and the FY2025 full-year result was $9.4 million, up 5.54% from the prior year.
• Accumulated Expenses grew to $9.4 million in Q4 2025, from $9.1 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $9.4 million in Q4 2025 to a low of $22000.0 in Q2 2021.
• A 5-year average of $4.4 million and a median of $4.3 million in 2022 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses plunged 99.33% in 2024 and soared 18893.75% in 2025, its largest moves.
• Tracing ETON's Accumulated Expenses over 5 years: stood at $1.4 million in 2021, then jumped by 168.08% to $3.7 million in 2022, then surged by 47.08% to $5.4 million in 2023, then jumped by 65.5% to $8.9 million in 2024, then rose by 5.54% to $9.4 million in 2025.
• Business Quant data shows ETON's Accumulated Expenses at $9.4 million in Q4 2025, $9.1 million in Q3 2025, and $7.5 million in Q2 2025.